Substance-Related Disorders

Search with Google Search with Bing
Information
Disease name
Substance-Related Disorders
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05229770 Active, not recruiting N/A Effect of Fruit Smoothie Supplementation on Psychological Distress Among People Receiving Opioid Agonist Therapy April 7, 2022 December 2026
NCT05242848 Active, not recruiting N/A Integrated Exercise Program in Opioid Agonist Therapy Clinics April 7, 2022 December 2026
NCT03162081 Active, not recruiting Medication Misuse and Dependence Among Elderly May 3, 2017 December 2023
NCT05666856 Active, not recruiting N/A Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones November 29, 2022 September 22, 2024
NCT05907174 Active, not recruiting N/A Siyakhana Peer: Evaluating a Peer Recovery Coach Model to Reduce Substance Use Stigma in South African HIV Care May 17, 2023 August 1, 2024
NCT05063097 Active, not recruiting Addiction in Intensive Cardiac Care Units April 6, 2021 April 2023
NCT05290025 Active, not recruiting N/A Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco April 7, 2022 December 2026
NCT04162184 Active, not recruiting N/A Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder December 16, 2019 June 2024
NCT03925220 Active, not recruiting N/A Testing a Brief Substance Misuse Preventative Intervention for Parents/Guardians of 5th-7th Grade Students March 6, 2019 June 30, 2025
NCT00000251 Completed Phase 2 Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 April 1994 January 1996
NCT00000252 Completed Phase 2 Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 June 1994 June 1996
NCT00000253 Completed N/A Effects of Nitrous Oxide: A Dose-Response Analysis - 5 November 1994 March 1996
NCT00000254 Completed Phase 2 Isoflurane at Subanesthetic Concentrations - 6 January 1995 September 1995
NCT00000255 Completed Phase 2 Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 April 1995 May 1996
NCT00000256 Completed N/A Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 August 1995 November 1996
NCT00000257 Completed N/A Effects of Alcohol History on Effects of Nitrous Oxide - 9 September 1995 April 1997
NCT00000258 Completed N/A Role of Instructions in Nitrous Oxide Effects and Choice - 10 April 1996 November 1997
NCT00000259 Completed N/A Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 August 1996 November 1997
NCT00000260 Completed N/A Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 June 1997 January 1998
NCT00000261 Completed Phase 2 Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 November 1997 October 1998
NCT00000262 Completed N/A Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 November 1996 February 1999
NCT00000263 Completed N/A Effects of Combined Alcohol and Nitrous Oxide Intake - 15 January 1997 October 1998
NCT00000264 Completed N/A Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 September 1997 October 1999
NCT00000265 Completed Subjective Effects of Nitrous Oxide in Dental Patients - 17 July 1997 January 2002
NCT00000269 Completed Phase 2 Pergolide Treatment for Substance Abusers - 4 October 1995 December 2001
NCT00000271 Completed Phase 2 New Approaches to Cocaine Abuse Medications (A) - 6 January 1995 October 2002
NCT00000273 Completed Phase 2 A Laboratory Model for Heroin Abuse Medications - 8 August 1995 November 2005
NCT00000274 Completed Phase 2 Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 March 1997 May 1999
NCT00000279 Completed Phase 2 Novel Medications for Opiate Detoxification - 4 September 1994 August 1999
NCT00000281 Completed Phase 2 Pharmacotherapy for Schizophrenic Drug Users - 6 September 1994 August 1999
NCT00000292 Completed Phase 1 Acute Withdrawal From Smoked Cocaine - 9 April 1996 December 2001
NCT00000304 Completed Phase 2 Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 August 1997 August 2001
NCT00000311 Completed Phase 3 Combining Behavioral Treatment With Agonist Maintenance - 1 February 1995 February 1999
NCT00000317 Completed Phase 2 Early Phase II Trials for Cocaine Medication Development - 1 August 1996 July 1999
NCT00000318 Completed Phase 2 Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 December 1994 August 2007
NCT00000319 Completed Phase 2 Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 June 1996 January 2005
NCT00000321 Completed Phase 4 Methamphetamine Abuse Treatment in Patients With AIDS - 1 October 1996 December 2001
NCT00000343 Completed Phase 4 Brain Changes in Stimulant Dependent Subjects - 8 April 1996
NCT00000352 Completed Phase 2 Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1 December 1996 April 1998
NCT00000353 Completed Phase 2 Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 October 1996 October 1997
NCT00000354 Completed Phase 1 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 July 1996 December 1997
NCT00000355 Completed Phase 1 Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 November 1994 March 1996
NCT00000356 Completed Phase 2 Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5 June 1991 October 1992
NCT00000357 Completed Phase 2 Buprenorphine Maintenance for Opiate Dependence - 6 June 1992 October 1993
NCT00000358 Completed Phase 1 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
NCT00000388 Completed Phase 4 Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) September 1998 November 1999
NCT00015028 Completed Phase 2 Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 November 1996 January 1997
NCT00015041 Completed Phase 1 Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 November 1996 July 1998
NCT00015171 Completed Phase 3 Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 April 1996 June 1997
NCT00015210 Completed Phase 2 Nefazodone in the Treatment of Cocaine Dependence and Depression - 4 February 1997
NCT00015223 Completed Phase 2 Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5 June 1997 August 1999
NCT00015236 Completed Phase 4 Modeling Impaired Judgement in Cocaine Abusers - 6 March 1997
NCT00015249 Completed Phase 1 Prepulse Inhibition of Startle in Cocaine Dependence - 7 February 1997 May 1998
NCT00015275 Completed Phase 4 Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015301 Completed Phase 4 Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11 December 2003 August 2005
NCT00015340 Completed Phase 4 Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14 August 1999 September 2001
NCT00018655 Completed Phase 2 Integrated Intervention for Substance Abusers With Depressive Disorders April 2000 September 2012
NCT00032981 Completed Phase 3 Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 May 2001 August 2004
NCT00032994 Completed Phase 3 Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1 April 2001 October 2002
NCT00033007 Completed Phase 3 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1 April 2001 February 2003
NCT00033020 Completed Phase 3 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1 April 2001 February 2003
NCT00033033 Completed Phase 2 Reserpine for the Treatment of Cocaine Dependence - 1 July 2001 May 2003
NCT00033111 Completed Phase 2 A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 June 2001 April 2004
NCT00043693 Completed N/A Family Intervention for Mental Illness and Substance Abuse April 2002 December 2008
NCT00061113 Completed Phase 4 Substance Dependent Teens - Impact of Treating Depression Study 1 - 1 February 2001 August 2006
NCT00067171 Completed Phase 3 Telephone Enhancement Procedure for Continuing Care - 1 January 2003 January 2004
NCT00071513 Completed Phase 1 Middle School to High School Transition Project: Depression and Substance Abuse Prevention March 2003 June 2007
NCT00078143 Completed Phase 3 Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1 October 2003 April 2006
NCT00078156 Completed Phase 3 Women's Treatment for Trauma and Substance Use Disorders - 1 January 2004 October 2005
NCT00078169 Completed Phase 3 Motivational Enhancement for Spanish Speaking Individuals - 1 November 2003 October 2005
NCT00102362 Completed Phase 3 Job-Seekers Training for Patients With Drug Dependence - 1 December 2004 October 2006
NCT00108407 Completed N/A Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse October 2004
NCT00118534 Completed N/A Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder July 2004 June 2009
NCT00000216 Completed Phase 3 Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 January 2005
NCT00137267 Completed N/A A Brief Community Linkage Intervention for Dually Diagnosed Individuals June 2005 June 2009
NCT00137306 Completed Phase 4 Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs January 2004 October 2006
NCT00142870 Completed Phase 2 Effectiveness of Bupropion in Treating Marijuana Dependent Individuals March 2005 May 2006
NCT00149552 Completed N/A Zinc Therapy in HIV Infected Individuals Who Abuse Drugs June 2001 January 2007
NCT00149656 Completed N/A The Effects of Nutritional Supplementation and Drug Abuse on HIV June 2003 April 2013
NCT00158184 Completed Phase 2 Prescription Opioid Effects in Abusers Versus Non-Abusers June 2004 June 2009
NCT00158210 Completed Phase 1 Rivastigmine For Methamphetamine Dependent Individuals May 2006 March 2007
NCT00158288 Completed Phase 2 The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 March 1997 August 2001
NCT00183768 Completed Phase 3 Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users September 1999 February 2003
NCT00184223 Completed N/A Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use October 2004 June 2005
NCT00194480 Completed Phase 4 Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users April 2003 June 2007
NCT00218322 Completed Phase 4 Effectiveness of ATMX in Treating Adolescents With ADHD and SUD September 2004 April 2006
NCT00218582 Completed Phase 1/Phase 2 Effectiveness of Self-Help for Dually-Diagnosed Persons - 1 March 2003 March 2007
NCT00218634 Completed N/A Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1 February 2005 July 2009
NCT00218725 Completed Phase 1 Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder May 2005 October 2005
NCT00228007 Completed Phase 3 Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users September 2000 September 2004
NCT00229983 Completed Phase 2 Medical Office Intervention for Adolescent Drug Use June 2004 May 2010
NCT00230022 Completed Phase 1 Pilot Clinical Trial of Computer-based Motivational Intervention - 1 October 2004 April 2005
NCT00230048 Completed Phase 2 Interactive Motivational Media for Perinatal Drug Abuse - 3 September 2001 February 2006
NCT00230100 Completed Phase 1 The Women's Recovery Group Study: Stage I Trial March 2003 October 2005
NCT00232284 Completed Phase 2 Treatment of Comorbid Depression and Substance Abuse in Young People September 2004 May 2009
NCT00232336 Completed Phase 4 Quetiapine for Cocaine Use and Cravings October 2003 January 2006
NCT00247572 Completed Phase 2 Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories September 2005 November 2005
NCT00248092 Completed Phase 1/Phase 2 Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse January 2006 May 2006
NCT00249561 Completed Phase 1/Phase 2 Colorado Women's TC Project September 2001 September 2007
NCT00249652 Completed Phase 1/Phase 2 Transplant and Addiction Project (TAP) - 1 September 2003 September 2009
NCT00249756 Completed N/A Re-Entry MTC for Offenders With MICA Disorders August 2005 April 2010
NCT00262223 Completed Phase 2 Combined Treatment for Alcohol-Dependent Individuals With PTSD May 2006 July 2013
NCT00264329 Completed Phase 3 Transitional Case Management Study November 2004 May 2008
NCT00312455 Completed Phase 2 Effects of Fatty Acid Supplementation on Substance Dependent Individuals July 2004 July 2005
NCT00316277 Completed Phase 3 Prescription Opioid Addiction Treatment Study (POATS) May 2006 January 2013
NCT00317460 Completed Phase 4 Buprenorphine and Integrated HIV Care September 2005 October 2012
NCT00336180 Completed Phase 2/Phase 3 Adolescent Drug and HIV Prevention in South Africa September 2003 April 2008
NCT00344214 Completed N/A STD Risk Reduction for Heterosexual Methamphetamine Users October 2006 August 2012
NCT00419029 Completed N/A Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment September 2007 September 2011
NCT00438685 Completed Phase 1 Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders October 2004 September 2010
NCT00514839 Completed Phase 2 Brief Intervention for Prescription Drug Misuse in General Hospital November 2005 February 2009
NCT00573287 Completed N/A First Episode Schizophrenia and Cannabis-Related Disorder Study June 2006 December 2011
NCT00593034 Completed Medical Office Intervention for Adolescent Drug Use - Attention Study Supplement February 2007 February 2008
NCT00607269 Completed Phase 2/Phase 3 Voucher-Based Incentives in a Prevention Setting April 2005 February 2008
NCT00622219 Completed N/A Mentored Clinical Career Award in Adolescent Substance Abuse March 2008 August 31, 2013
NCT00661674 Completed N/A Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal April 2008 August 2008
NCT00685451 Completed Phase 1/Phase 2 Cognitive Therapy for PTSD in Addiction Treatment November 2004 November 2006
NCT00690352 Completed Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders March 5, 2008 August 20, 2008
NCT00694226 Completed N/A Brief Intervention in Substance Use in Adolescent Psychiatric Patients March 2004
NCT00700973 Completed Phase 2/Phase 3 Treating Violence-Prone Substance Use Disorder Patients February 2009 November 2013
NCT00763542 Completed Phase 2 Combined Treatment for Patients With Comorbid Substance Use Disorders and Post-traumatic Stress Disorder (PTSD): an Integration of Cognitive-behavioral Treatment (CBT) and Trauma-focused Structured Writing Therapy July 2008 May 2013
NCT00798538 Completed Phase 4 Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) August 2005 August 2010
NCT00809445 Completed Phase 3 Rapid HIV Testing and Counseling in Drug Abuse Treatment January 2009 February 2010
NCT00831883 Completed N/A Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents February 2009 January 2011
NCT00877331 Completed N/A Brief Intervention in Primary Care for Problem Drug Use and Abuse April 2009 September 2014
NCT00886886 Completed Phase 1 Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) April 2009 March 2010
NCT00135759 Completed Phase 2 Addition of Naltrexone to Methadone Taper April 2005 July 2006
NCT00000217 Completed Phase 2 Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 September 1990
NCT00000218 Completed Phase 4 Pharmacotherapy and Intensive Treatment - 2 June 2005
NCT00000241 Completed Phase 2 Flupenthixol Decanoate in Methamphetamine Smoking - 1 February 1994 May 1996
NCT00000242 Completed Phase 2 Carbamazepine Treatment of Cocaine Dependence - 1 October 1, 1992 January 25, 1997
NCT00000245 Completed Phase 2 Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1 May 1994 December 2001
NCT00000246 Completed Phase 2 Rapid Benzodiazepine Detoxification Using Flumazenil - 1 January 1993 December 1994
NCT00000249 Completed Phase 2 Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 September 1993 June 1995
NCT00000250 Completed Phase 2 Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 December 1993 May 1995
NCT02335125 Completed N/A A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot February 2015 August 2016
NCT02355080 Completed Phase 2/Phase 3 A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results April 2016 July 2017
NCT02358226 Completed Phase 3 HIV & Drug Abuse Prevention for South African Men May 2016 January 2020
NCT02388243 Completed N/A The Computer-based Drug and Alcohol Training Assessment in Kenya September 2014 December 2015
NCT02420561 Completed N/A Motivational Interviewing to Reduce Substance Use Among Depression Patients October 2010 August 2014
NCT02439762 Completed N/A Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders July 2015 June 12, 2020
NCT02564991 Completed Study of Structural Imaging February 29, 2016 March 18, 2020
NCT02570360 Completed N/A Exercise and Treatment-as-usual in Substance Use Treatment Outcomes September 2015 September 2016
NCT02655354 Completed N/A A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity October 2015 November 2019
NCT02674477 Completed N/A Treatment Engagement With Technology-assisted Treatment February 29, 2016 September 2018
NCT02680899 Completed N/A Adolescent Mental Health InSciEd Out February 2016 May 2016
NCT02701660 Completed N/A Adherence to Polypharmacy in Patients With Opioid Substitution Therapy Using Electronics November 2014 August 30, 2016
NCT02702193 Completed N/A SET-Recovery/Healthy Home July 2013 August 2017
NCT02707887 Completed N/A Technology Enhanced Behavioral Activation Treatment for Substance Use January 2016 December 2020
NCT02715440 Completed N/A Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions February 2012 August 2015
NCT02715557 Completed N/A Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers September 2014 September 2017
NCT02755103 Completed N/A Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD June 1, 2016 October 1, 2021
NCT02785393 Completed Phase 1 DOX as a Potential Treatment for Methamphetamine Dependence March 2011 March 2016
NCT02786615 Completed N/A Increasing MSM in the Continuum of Care in Kazakhstan June 27, 2018 April 30, 2022
NCT02790476 Completed N/A Behavioral Insights to Encourage Judicious Prescribing of Opioids January 27, 2017 February 27, 2018
NCT02797990 Completed Conflict Between Maternal Autonomy and Child Health in Substance-use May 2016 September 2016
NCT02804295 Completed N/A Collaborative Care From the ED for Trauma Patients With Prescription Drug Misuse January 2015 March 2016
NCT02829970 Completed N/A Helping College Students With ADHD Lead Healthier Lifestyles September 2015 September 2019
NCT02846649 Completed N/A A Text Messaging Program to Help Prevent Early Opioid Relapse August 2016 December 2016
NCT02888249 Completed N/A Behavioral Economic Purchasing Decisions for Cigarettes of Varied Compositions August 25, 2017 November 10, 2021
NCT02903251 Completed Phase 3 Oxytocin and Alcohol Withdrawal and Dependence October 2016 January 22, 2018
NCT02907944 Completed N/A Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation September 2016 September 30, 2021
NCT02930577 Completed Treatment Adherence in Substance Users October 2015 August 2016
NCT02943408 Completed N/A Development of a Patient Centered Mental Health Intervention for Recent Veterans July 31, 2017 June 1, 2022
NCT02945371 Completed N/A Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life September 2014 May 2016
NCT02951143 Completed N/A Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace January 2017 November 2019
NCT02964845 Completed N/A Women's Initiative Supporting Health Increasing Healthcare Access January 13, 2017 July 31, 2019
NCT02977988 Completed N/A Women's Treatment and Early Recovery October 15, 2015 June 30, 2019
NCT03048552 Completed N/A Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3 November 17, 2016 December 1, 2018
NCT03075501 Completed Phase 4 Interactions Between Drug Effects and Environments II November 2015 July 2020
NCT03166709 Completed N/A Preventing Addiction Related Suicide (PARS) May 5, 2017 May 28, 2020
NCT03258905 Completed Phase 2 Phone App for Grounding November 1, 2019 September 3, 2020
NCT03306173 Completed N/A COMET Study 1: Filter Ventilated Cigarette Substitution in the ETM August 8, 2018 March 10, 2020
NCT03339024 Completed Phase 3 Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study November 1, 2017 March 31, 2019
NCT03413631 Completed N/A A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women October 18, 2011 December 31, 2015
NCT03414411 Completed Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F Study February 20, 2018 April 27, 2023
NCT03705143 Completed N/A Behavioral Activation for Heroin Use in China: A Randomized Controlled Trial June 4, 2018 December 5, 2018
NCT03856593 Completed N/A Encouraging Judicious Prescribing of Opioids in Los Angeles County April 5, 2019 August 8, 2021
NCT03882125 Completed N/A Mindfulness-Based Relapse Prevention for Methadone Maintenance February 15, 2015 June 27, 2015
NCT03930446 Completed Early Phase 1 Alcohol, Behavior, and Brain Imaging January 1, 2016 May 30, 2019
NCT03944954 Completed Early Phase 1 Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults July 15, 2017 December 13, 2023
NCT04210713 Completed Phase 1 Neuroimmune Dysfunction in Alcohol Use Disorder February 3, 2020 September 20, 2023
NCT04235582 Completed N/A Incentives to Decrease Opioid Use - Pilot August 25, 2020 May 15, 2021
NCT04250077 Completed N/A We The Village Family Support Study January 9, 2020 June 30, 2020
NCT04405414 Completed EffectS of CAnnabidiol in Patients: Evaluation May 6, 2020 July 26, 2021
NCT04458987 Completed N/A Addictology Expert Patients' Fields of Intervention June 19, 2020 May 19, 2021
NCT04556552 Completed Phase 3 Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders November 13, 2020 September 13, 2022
NCT04622995 Completed Benzodiazepines in Opiate Replacement Therapy August 1, 2021 December 31, 2022
NCT04659954 Completed N/A Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction January 7, 2022 February 10, 2023
NCT04707599 Completed N/A Telephone Reminder to Increase Appointment Rates April 1, 2015 December 31, 2016
NCT05060445 Completed Mental Health in Latin American Countries With Different Economic Incomes During the Covid-19 Pandemic. November 22, 2021 March 13, 2022
NCT05075629 Completed Anxiety, Depression and Substance Use in Undergraduate Health Science Students During the Covid-19 Pandemic. October 12, 2021 March 31, 2022
NCT05282173 Completed N/A Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa June 8, 2022 August 1, 2023
NCT05564559 Completed N/A Multifamily Group Psychoeducation for SUD's in Turkey October 10, 2022 August 30, 2023
NCT05830773 Completed N/A Resonance Breathing Intervention Opioid Use Disorder March 9, 2021 August 31, 2023
NCT05875142 Completed N/A Scalable Digital Delivery of Evidence-based Training for Professionals to Maximize Treatment Rates of OUD in Families May 23, 2023 September 26, 2023
NCT00895804 Completed Phase 1 Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine) June 2001 March 2002
NCT00944554 Completed Phase 4 Relapse Prevention With Varenicline October 2008 May 2011
NCT00958217 Completed N/A Intervention for Veterans With Depression, Substance Disorder, and Trauma December 2009 May 2014
NCT00970372 Completed Dual-Diagnosis and Compulsory Treatment September 2008 May 2012
NCT00990067 Completed Phase 1 Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) November 2009 May 2010
NCT01006707 Completed N/A Functional Magnetic Resonance Imaging of Opioid Withdrawal in Healthy Human Volunteers November 2010 July 2013
NCT01018654 Completed Phase 2 Validating Interventions for Diverse Adolescents June 2010 February 2013
NCT01027754 Completed Phase 4 Smoking Cessation Treatment for Methadone Maintenance Patients August 2009 September 2011
NCT01046539 Completed Phase 1 Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults January 2010 July 2010
NCT01117753 Completed Phase 2 Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders July 2009 June 2014
NCT01127932 Completed N/A Developing an Intervention to Address Suicide Risk During Substance Use Disorder April 2010 September 2011
NCT01136278 Completed Phase 1 Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA) July 2010 December 2010
NCT01148342 Completed Phase 1 Neurobiology and Pharmacokinets of Acute MDMA Administration February 10, 2004 July 18, 2012
NCT01253993 Completed Impaired Decision-making in Adolescents April 2006 September 2007
NCT01270672 Completed N/A Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA) January 2011 May 2011
NCT01318538 Completed N/A Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial August 2008 June 2012
NCT01337973 Completed N/A Preventing Violence Among Veterans in Substance Use Disorder Treatment June 20, 2012 December 1, 2017
NCT01344382 Completed Phase 1/Phase 2 Family Training Program for Parents of Substance Using Adolescents January 2011 May 2016
NCT01365247 Completed N/A Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD) September 2008 December 2014
NCT01386177 Completed Phase 1 Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA) July 2011 January 2012
NCT01406899 Completed Phase 1 Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT) January 2010 December 2013
NCT01414907 Completed N/A Study of Effectiveness of Adding the Health Promotion and Rehabilitation for Treatment for Alcohol and Drug Abusers October 2010 September 2015
NCT01438346 Completed N/A Behavioral Treatment for Substance Abuse August 2011 August 2012
NCT01456338 Completed Phase 2 Cognitive Behavioral Therapy for Post Traumatic Stress Disorder in Addiction Treatment June 2007 August 2009
NCT01457391 Completed Phase 3 Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment December 2010 April 2014
NCT01457404 Completed Phase 3 Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders February 2011 June 2015
NCT01539525 Completed N/A Screening to Augment Referral to Treatment- Project START September 5, 2011 January 28, 2015
NCT01560221 Completed Phase 1 Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution October 2012 December 2014
NCT01563718 Completed Phase 4 Pre-Release VIVITROL for Opioid Dependent Inmates March 2012 August 2015
NCT01573416 Completed Phase 3 "Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care." December 2011 April 2013
NCT01591239 Completed N/A Home-Based Program to Help Parents of Drug Abusing Adolescents September 2011 April 2016
NCT01633138 Completed N/A Performance-based Reinforcement to Enhance Cognitive Remediation Therapy September 2012 December 2014
NCT01671501 Completed N/A Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients March 2013 August 2017
NCT01690494 Completed N/A Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders June 11, 2013 September 30, 2017
NCT01736995 Completed N/A Family and Adolescent Motivational Incentives for Leveraging Youth July 2012 April 2018
NCT01740115 Completed Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort November 2012 August 2016
NCT01751217 Completed N/A Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents February 2012 November 30, 2016
NCT01771237 Completed N/A HIV Prevention Among Vulnerable Male Youth July 2007 January 2011
NCT01771874 Completed Phase 1 Influence of Bupropion on the Effects of MDMA January 2013 September 2013
NCT01831999 Completed N/A Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients June 2012 May 2016
NCT01891656 Completed N/A Motivational Assessment Program to Initiate Treatment June 2012 February 2016
NCT01966432 Completed N/A Screening, Brief Intervention, and Referral to Treatment in Primary Care August 2013 June 2016
NCT01984177 Completed Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence June 2013 June 2016
NCT02017821 Completed N/A The Effect of Aerobic Endurance Training in Patients With Drug Addiction August 2012 January 2014
NCT02083523 Completed Phase 1 Project CHOICE: Efficacy Testing of CHOICE and CHOICE+Normative Feedback Interventions March 2013 August 2013
NCT02101840 Completed Phase 4 Abuse Liability of Controlled-Release Oxycodone Formulations February 2014 December 2014
NCT02125539 Completed Phase 2 Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment September 2014 June 2015
NCT02218970 Completed N/A The Effect of Muscular Strength Training in Patients With Drug Addiction September 2012 January 2015
NCT02233738 Completed N/A Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services September 30, 2015 July 17, 2018
NCT02308462 Completed N/A Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents November 2014 June 2019
NCT02309021 Completed N/A PHAST: Physical Activity in Substitution Therapy November 2014 November 2015
NCT02318797 Completed N/A Optimizing Behavioral Health Homes for Adults With Serious Mental Illness October 2013 January 2017
NCT06415994 Enrolling by invitation Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder February 13, 2024 December 1, 2029
NCT06084221 Enrolling by invitation N/A Fatal Overdose Review Teams - Research to Enhance Surveillance Systems September 21, 2023 September 30, 2027
NCT04499079 Enrolling by invitation N/A Alliances to Disseminate Addiction Prevention and Treatment (ADAPT) June 1, 2020 April 30, 2025
NCT05998005 Enrolling by invitation N/A First Face Training Evaluation in Tribal Communities August 30, 2023 June 2025
NCT05633043 Not yet recruiting Validation of the Cannabis Abuse Screening Test in General Practice(GP-CAST) January 1, 2023 June 1, 2024
NCT05910580 Not yet recruiting N/A Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years September 1, 2024 May 31, 2026
NCT06023459 Not yet recruiting Phase 3 Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) July 1, 2024 December 30, 2024
NCT06387290 Not yet recruiting N/A Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits May 6, 2024 May 1, 2030
NCT05476601 Not yet recruiting N/A CMAP Plus Intervention for Self-harm in Individuals With Substance Use Disorder in Pakistan August 2023 December 2024
NCT05763537 Not yet recruiting N/A Understanding the Role of Doulas in Supporting People With PMADs July 1, 2024 February 2025
NCT05341830 Not yet recruiting N/A Housing for Recovery Initiative April 18, 2022 March 31, 2026
NCT06208839 Not yet recruiting N/A Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders March 2024 April 2027
NCT06236100 Recruiting N/A Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program November 29, 2023 September 29, 2027
NCT06008990 Recruiting Maternal Brain Imaging in Opioid Use Disorder August 1, 2023 July 31, 2025
NCT04959461 Recruiting N/A Preventing Impaired Driving Among Adolescents January 1, 2022 June 30, 2024
NCT04969081 Recruiting N/A Impact of Work Activity on SUD Outcomes January 3, 2022 December 31, 2028
NCT05054738 Recruiting N/A CRP and S&A for Inpatient Veterans September 6, 2022 December 31, 2025
NCT04157062 Recruiting N/A An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder September 30, 2021 October 1, 2025
NCT05558345 Recruiting N/A Expression of Stress Markers During Meth Treatment (EXPRESS+) September 1, 2022 March 31, 2026
NCT05489068 Recruiting N/A Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment March 16, 2022 December 2024
NCT05299515 Recruiting N/A Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence April 5, 2022 March 1, 2025
NCT05400252 Recruiting N/A Whole Health in VA Mental Health: Omnis Salutis February 1, 2023 October 31, 2026
NCT04141202 Recruiting Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder February 25, 2020 July 25, 2024
NCT05834881 Recruiting N/A Reducing Drug Use in Justice-Involved Emerging Adults May 26, 2023 January 31, 2025
NCT04228276 Recruiting N/A Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation February 5, 2021 April 30, 2024
NCT05873517 Recruiting Phase 1 Trauma-Focused Intervention With Women Experiencing Homelessness August 1, 2022 September 1, 2024
NCT05648786 Recruiting Phase 2 Socializing a Science-Based Digital Therapeutic for Substance Use Disorders November 9, 2022 December 31, 2023
NCT05886582 Recruiting Phase 2 Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder September 11, 2023 June 2026
NCT03833804 Recruiting N/A Data-driven Identification for Substance Misuse February 1, 2023 March 30, 2025
NCT04567784 Recruiting Phase 2 Neuroimaging and CBD for Opiod Use Disorder November 12, 2020 November 12, 2025
NCT05973838 Recruiting N/A Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention June 15, 2023 September 1, 2027
NCT04637581 Recruiting N/A Wraparound for High-risk Families With Substance Use Disorders: Examining Family, Child, and Parent Outcomes November 16, 2020 September 30, 2024
NCT05322954 Recruiting Phase 1 Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder March 3, 2023 May 2025
NCT04404348 Suspended N/A Cognitive Rehabilitation for Opioid Abuse-related Cognitive Impairment March 6, 2020 December 2020
NCT04934553 Suspended N/A Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression May 20, 2021 June 2023
NCT00334217 Terminated N/A Cognitive Remediation in Early Substance Abuse Treatment August 2005 December 2008
NCT02423018 Terminated Phase 4 Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms April 2015 March 2016
NCT00430573 Terminated Phase 2 Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use February 2007 June 2009
NCT03285256 Terminated N/A Effects of Repeated Memory Training on Memory Function and Addiction Related Processes May 1, 2018 October 1, 2019
NCT00514202 Terminated Phase 2 Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD) August 2007 October 2008
NCT00726960 Unknown status Phase 1 Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers January 2008 June 2010
NCT05350033 Unknown status N/A Transcranial Direct Current Stimulation on Inhibitory Control in Addictions. April 5, 2021 December 31, 2022
NCT02594306 Unknown status N/A Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation October 2015 November 2016
NCT00504413 Unknown status Phase 1 Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone July 2007 January 2011
NCT03114007 Unknown status N/A Integrated Prevention and Collaborative Care for Youth Mental Health April 24, 2017 December 14, 2021
NCT03119129 Unknown status N/A The Development and Evaluation of the Ho'Ouna Pono Drug Prevention Curriculum September 1, 2016 April 15, 2018
NCT03264872 Unknown status Phase 2 Peer MI for Substance-using Emerging Adults March 8, 2017 October 31, 2021
NCT02386280 Unknown status Phase 1/Phase 2 Prevention of Drug Use in Adolescence: Intervening in Parenting Styles August 2014 March 2016
NCT00302575 Unknown status N/A Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees February 2005 August 2007
NCT01354236 Unknown status Mental Health Related to School Dropout in Luxembourg January 2011
NCT03606759 Unknown status N/A Evaluation of the Efficacy of the Individually Adjusted Therapy Scale (ATI) on the Addiction Severity July 31, 2019 April 30, 2023
NCT00033124 Unknown status Phase 2 A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1 July 2001 June 2002
NCT04291534 Unknown status Quality of Life and Addiction Among Hospital Night Workers June 15, 2020 June 1, 2023
NCT03866694 Unknown status N/A Growing Together: Women in Opioid Treatment and Their Infants December 13, 2018 December 30, 2021
NCT00086398 Unknown status Phase 2 Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1 September 2001
NCT03902405 Unknown status N/A Computerized Exercise to Alter Stimulant Approach Responses June 11, 2018 March 31, 2022
NCT00957775 Unknown status N/A Computer-delivered Psychosocial Intervention for Adolescent Substance Use Disorders August 2009 July 2011
NCT03090269 Withdrawn Phase 2 Methylphenidate for Cocaine Dependence June 1, 2018 March 30, 2019
NCT01224002 Withdrawn A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse Methamphetamine September 2010 November 2012
NCT00891631 Withdrawn Phase 1/Phase 2 Primary Care iSBIRT to Reduce Serious Teen Health Risks September 2009 September 2011
NCT00123578 Withdrawn Phase 1/Phase 2 GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 August 2004 August 2008
MeSH unique ID (MeSH (Medical Subject Headings))
D019966